@article{H. TEAIMA_I. GEBRIL_ALLAH_EL-NABARAWI_2022, title={NIOSOMES VERSUS PRONIOSOMES AS PROMISING DRUG DELIVERY SYSTEMS IN TREATMENT OF DIABETES MELLITUS}, volume={14}, url={https://journals.innovareacademics.in/index.php/ijap/article/view/44039}, DOI={10.22159/ijap.2022v14i5.44039}, abstractNote={<p>Diabetes Mellitus (DM) has emerged as an epidemic that has affected millions of people globally in the last few decades. Conventional antidiabetic dosage forms have a lot of problems that necessitate searching for novel drug delivery systems to overcome these drawbacks. Niosomes and proniosomes have been used to carry a wide variety of antidiabetic drugs achieving controlled and sustained release, which improves patient compliance. This review article describes the fundamental aspects of niosomes and proniosomes, including their structural components, methods of preparation, advantages and drawbacks, characterization, factors affecting niosomes formation along with their application in the treatment of diabetes. It also highlights the participation of other drug delivery systems in the treatment of diabetes done, mainly in the last decade.</p>}, number={5}, journal={International Journal of Applied Pharmaceutics}, author={H. TEAIMA, MAHMOUD and I. GEBRIL, MOSTAFA and ALLAH, FATHY I. ABD and EL-NABARAWI, MOHAMED A.}, year={2022}, month={Sep.}, pages={32–40} }